序贯心脏及自体干细胞移植治疗轻链型心脏淀粉样变性 - Suppr

Suppr

超能文献

Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis.

作者信息

Huh Jin-Young, Seo Seyoung, Suh Cheolwon, Huh Jooryung, Yoon Dok Hyun, Kim Jae-Joong

机构信息

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Blood Res. 2017 Sep;52(3):221-224. doi: 10.5045/br.2017.52.3.221. Epub 2017 Sep 25.

DOI:10.5045/br.2017.52.3.221

PMID:29043240

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5641517/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138d/5641517/e7c98f3a2db1/br-52-221-g001.jpg

相似文献

Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis.序贯心脏及自体干细胞移植治疗轻链型心脏淀粉样变性

Blood Res. 2017 Sep;52(3):221-224. doi: 10.5045/br.2017.52.3.221. Epub 2017 Sep 25.

[Prognostic factors in light chain amyloidosis].[轻链淀粉样变性的预后因素]

Orv Hetil. 2015 Sep 27;156(39):1577-84. doi: 10.1556/650.2015.30241.

Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.自体造血干细胞移植治疗轻链淀粉样变性后，出现进行性肾轻链淀粉样变性，但检测不到游离单克隆轻链。

Arch Pathol Lab Med. 2013 Sep;137(9):1304-8. doi: 10.5858/arpa.2012-0159-CR.

Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.三器官以上受累的轻链淀粉样变性患者自体干细胞移植的结果。

Biol Blood Marrow Transplant. 2019 Aug;25(8):1520-1525. doi: 10.1016/j.bbmt.2019.04.024. Epub 2019 May 2.

[Heart transplantation and the subsequent treatment of AL amyloidosis].[心脏移植与AL淀粉样变性的后续治疗]

Vnitr Lek. 2013 Feb;59(2):136-47.

Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement.达雷妥尤单抗、泊马度胺和地塞米松作为系统性轻链淀粉样变伴晚期心脏受累患者自体干细胞移植的桥接治疗。

J Oncol Pharm Pract. 2019 Jun;25(4):1021-1025. doi: 10.1177/1078155218815305. Epub 2018 Nov 26.

Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.体外膜肺氧合作为系统性轻链淀粉样变性所致急性心力衰竭的决策桥梁。

Am J Case Rep. 2015 Mar 24;16:174-81. doi: 10.12659/AJCR.892772.

Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies.心脏移植与心脏淀粉样变性：筛查方法与新的治疗策略。

J Heart Lung Transplant. 2012 Mar;31(3):325-31. doi: 10.1016/j.healun.2011.09.010. Epub 2011 Nov 3.

Primary systemic amyloidosis.原发性系统性淀粉样变性

Curr Treat Options Oncol. 2000 Apr;1(1):83-9. doi: 10.1007/s11864-000-0018-9.

[Heart transplantation in AL amyloidosis].[AL淀粉样变性中的心脏移植]

Lakartidningen. 2018 Mar 26;115:EY3F.

引用本文的文献

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis.心脏移植，单独进行或与肝脏和肾脏联合移植，是部分重度心脏淀粉样变性患者可行的治疗选择。

Transplant Direct. 2022 Jun 17;8(7):e1323. doi: 10.1097/TXD.0000000000001323. eCollection 2022 Jul.

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.2021 年免疫球蛋白轻链淀粉样变的诊断和治疗算法。

Blood Cancer J. 2021 May 15;11(5):90. doi: 10.1038/s41408-021-00483-7.

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.2018 年免疫球蛋白轻链淀粉样变性诊断与治疗算法

Blood Cancer J. 2018 May 23;8(5):44. doi: 10.1038/s41408-018-0080-9.

本文引用的文献

Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era.现代时代淀粉样心肌病心脏移植后的结局。

Am J Transplant. 2015 Mar;15(3):650-8. doi: 10.1111/ajt.13025. Epub 2015 Feb 3.

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.改良的轻链淀粉样变预后分期系统，纳入了心脏生物标志物和血清游离轻链检测。

J Clin Oncol. 2012 Mar 20;30(9):989-95. doi: 10.1200/JCO.2011.38.5724. Epub 2012 Feb 13.

Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.心脏移植后继以剂量密集美法仑和自体干细胞移植治疗轻链淀粉样变性和心力衰竭。

Transplantation. 2010 Oct 27;90(8):905-11. doi: 10.1097/TP.0b013e3181f10edb.

Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone.全身轻链型淀粉样变合并心脏受累且最初不符合干细胞移植条件并接受口服美法仑和地塞米松治疗的患者的生存预测因素。

Br J Haematol. 2008 Nov;143(3):369-73. doi: 10.1111/j.1365-2141.2008.07327.x. Epub 2008 Aug 4.

Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.心脏移植后自体干细胞移植治疗轻链（AL）淀粉样心肌病。

J Heart Lung Transplant. 2008 Aug;27(8):823-9. doi: 10.1016/j.healun.2008.05.016. Epub 2008 Jul 3.

Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.序贯心脏与自体干细胞移植治疗系统性AL淀粉样变性

Blood. 2006 Feb 1;107(3):1227-9. doi: 10.1182/blood-2005-08-3253. Epub 2005 Oct 6.

High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.大剂量美法仑与自体干细胞移植治疗 AL 型淀粉样变性患者：一项为期 8 年的研究。

Ann Intern Med. 2004 Jan 20;140(2):85-93. doi: 10.7326/0003-4819-140-2-200401200-00008.

High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant.

Bone Marrow Transplant. 1999 Oct;24(8):853-5. doi: 10.1038/sj.bmt.1702005.

The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.伴有心脏受累的免疫球蛋白轻链（AL）淀粉样变性的临床特征。

QJM. 1998 Feb;91(2):141-57. doi: 10.1093/qjmed/91.2.141.

The systemic amyloidoses.系统性淀粉样变性

N Engl J Med. 1997 Sep 25;337(13):898-909. doi: 10.1056/NEJM199709253371306.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验